The relationship between capsular type and virulence for mice was examined with 69 fresh human isolates of Streptococcus pneumoniae. These isolates represented eight capsular types or groups. Serologic and molecular weight differences in PspA (pneumococcal surface protein A) indicated that the strains were clonally distinct. Mice were infected intravenously with washed bacteria of all 69 isolates in sterile salt solutions. Twenty-eight of the isolates were also injected intraperitoneally to permit comparisons between the intravenous and intraperitoneal routes. With a few exceptions, there was concordance between the ability of strains to cause fatal infections by the two routes. About 30% of the 69 isolates were virulent for mice. The abilities of the isolates to kill mice and the length of time between inoculation and death were strongly associated with capsular type. All type 4 isolates, 40% of type 3 isolates, and 60% of group 6 isolates were virulent for mice; type 1 isolates were marginally virulent; and all type or group 14, 19, and 23 isolates were avirulent. Times to death were generally longer for mice infected with group 6 or type 1 than for those infected with type 3 or 4 pneumococci. There was no relationship between clinical diagnosis or tissue source of the isolates and virulence for mice.
Early reports indicated that some strains of Streptococcus pneumoniae, including those of types 14 and 37, were relatively avirulent in mice (16, 18, 27) . These reports were particularly significant because the method of choice for isolating pneumococci from patients had long been mouse inoculation (2, 13, 30) . Additional data indicating that not all pneumococci are virulent for mice came from a study demonstrating that 20% fewer pneumococcal isolates were obtained by intraperitoneal (i.p.) mouse inoculation of the patient sample mixed with medium than by direct plating on gentamicin-containing plates (9) . Other studies using mousepassaged laboratory strains have found that not all pneumococci are virulent for mice when injected by the intravenous (i.v.) route (6, 33) .
In previous studies, the numbers of strains of S. pneumoniae tested for virulence were small, and the capsular types of the pneumococci and the genetic backgrounds of the mice were not always defined. Most studies used i.p. inoculation (9, 18) , because it had commonly been used to isolate pneumococci from humans. When pneumococci are injected by the i.p. route, their ability to cause disease may not be a reflection of their ability to escape clearance by the reticuloendothelial system. In fact, studies with the rat have shown that pneumococci that are relatively avirulent when injected i.v. are highly virulent when injected i.p. (24) . To examine the potential virulence of washed pneumococci injected directly into the bloodstreams of mice, we studied 69 freshly stocked pneumococcal isolates and 7 mousepassaged laboratory strains. We also compared virulence by the i.v. and i.p. routes for 28 of these strains.
We infected immunologically normal BALB/cJ and immune-deficient CBA/N mice because they represent extremes of a broad spectrum of murine susceptibility to pneumococcal infection. The CBAIN mice carry the * Corresponding author.
X-linked recessive xid gene, which results in the X-linked immunodeficient (Xid) phenotype (1, 31) . Xid mice fail to make antibody responses to most carbohydrates (6-8, 22, 31) . Xid mice are generally more susceptible to infection with laboratory strains of S. pneumoniae than genetically related mice lacking the Xid defect (6, 8, 33) . The high susceptibility of Xid mice to pneumococcal infection has been shown to be because they lack "naturally occurring" antibody reactive with the phosphocholine determinants common to pneumococcal cell wall and cell membrane teichoic acids (8) . CBA/J mice lack the Xid defect but have a genetic background similar to that of CBA/N mice. Since CBA/J mice are more susceptible to pneumococci than BALB/cJ mice (6), the extreme susceptibility of CBA/N mice to pneumococcal infection is probably contributed to by genetic factors in addition to xid. (6, 8, 26, 33) . Laboratory strains DBL19F (type 19F) and DBL23F (type 23F) are avirulent in mice (33) .
Capsular and PspA typing. Pneumococci were serogrouped (types or groups 1, 3, 4, 6, 14, 19, and 23) with Danish antisera (Statens Seruminstitut, Copenhagen, Denmark) as previously described (14) . Group 6 capsular types 6A and 6B were identified by using antipneumococcal factor sera prepared by immunizing New Zealand White rabbits with Centers for Disease Control reference strain SP-85 (type 6A) or SP-86 (type 6B). The sera were cross-absorbed with the heterologous group 6 strain to remove crossreacting antibodies and tested in Quellung reactions according to methods established at the Centers for Disease Control (lla) . Pneumococcal surface protein A (PspA) types were determined by using seven monoclonal antibodies to PspA: Xi64, Xi126, SR4W4, 2A4, 1A4, 7D2, and XiR278. The detection of antibody reactivities, the assignment of PspA types based on reactivity with one or more monoclonal antibodies, and the determination of the relative molecular weight (Mr) of PspA have been previously described (10) .
Buoyant density. The determination of bacterial density was done according to Hakansson et al. (11, 15) , except that the Percoll (Pharmacia) was made isotonic (290 mosM) at pH 7.4 by the addition of phosphate buffer and NaCl. The Percoll used in the gradient (density, 1.033 to 1.099) contained 0.5% bovine serum albumin. The bacteria were suspended in pH 7.2 phosphate-buffered saline and layered at the top of the gradient prior to centrifugation for 10 min at 500 x g.
Mouse survival and 50% lethal dose (LD,O) studies. Washed pneumococci were prepared and enumerated as previously described (8) . Except as indicated, CBAIN mice were injected with 300 CFU of S. pneumoniae, and BALB/cJ mice were injected with 106 CFU. The numbers of CFU injected were based on the known susceptibilities of CBAIN (Xid) and BALB/cJ mice to infection with WU2 (type 3) and DBL1 (type 6B) pneumococci (5, 6, 33) and were chosen so that WU2 and DBL1 would be able to kill all infected BALB/cJ and CBAIN mice.
Female 6-to 8-week-old BALB/cJ and CBA/N mice from Jackson Laboratory, Bar Harbor, Maine, were housed for 2 to 4 weeks prior to use. For i.v. injections, groups contained from 4 to 15 mice; for i.p. injections, groups contained 3 to 7 mice. Deaths were recorded daily for 21 days. All mice alive at 22 days were considered to have survived the challenge. We defined mouse-virulent strains as those causing a median time to death of less than 10 days. The 10-day cutoff was chosen because very few strains showed a median time to death of 10 to 21 (34) . Mice living longer than 21 days were assigned a survival time of 22 days for calculation.
LD50s were determined by the method of probits (4). 
RESULTS
Relationship between i.v. virulence for mice and capsular type. When injected i.v., all type 4 strains tested were virulent for mice (defined as median day of death of '10 days) in CBA/N and/or BALB/cJ mice. In comparison, only 9 of 14 recent group 6 isolates and 2 of 5 recent type 3 isolates were virulent for mice (Fig. 1) ; similar distributions of virulent and avirulent strains were seen among the type 6A and 6B isolates (Table 1) . Only one of nine type 1 strains exhibited significant virulence in either CBA/N or BALB/cJ mice. Although none of the 34 type or group 14, 19, and 23 strains killed as many as 50% of the infected mice, one type 14 and one group 19 strain did kill an occasional mouse (Fig.   1 ).
Among the laboratory strains, the three type 3 strains, the type 6A strain, and the type 6B strain were all virulent for mice (Table 2) , as was expected from previous studies (6, 33) . Type 19F and 23F laboratory strains failed to exhibit virulence. The type 19F strain was previously observed to kill Xid mice only at doses above 105 CFU (33) . Although previously mouse passaged, the type 23F laboratory strain failed to kill even Xid mice at doses as high as 105 CFU (data not shown).
Many of the strains tested, particularly those of capsular types 3 and 4, exhibited similar median days to death in BALB/cJ and CBA/N mice when injected i.v. (Tables 1 and  2 ). This was probably in part because CBAIN mice were injected with 1/3,000 as many pneumococci as BALB/cJ mice to compensate for their generally greater susceptibility. Group 6 pneumococci frequently gave different results with BALB/cJ and CBAIN mice ( Table 2) .
We observed that, when injected i.v., type 1 and group 6 strains of pneumococci generally took significantly longer to kill mice than the type 3 or type 4 strain. This effect was most apparent when mice that lived were omitted from the calculation of median time to death. The average median times to death (± standard error) of CBA/N mice who died with infections of type 3, type 4, or group 6 pneumococci were 2.2 ± 0.5, 2.1 ± 0.7, and 5.9 ± 6 days, respectively. The median times to death with type 3 and type 4 strains were significantly shorter than that with group 6 strains (P < 0.002). The median times to death of BALB/cJ mice who died of infections with type 3, type 4, or group 6 strains were 2.5, 3.4, and 3.7 days, respectively. The reason that the BALB/c mice showed relatively rapid death even when infected with group 6 strains appeared to be related to the much larger Table 1 and Fig. 1 ). Three to seven BALB/cJ mice were infected i.p. with 106 CFU of each strain. The horizontal axis depicts the median day of death for each strain following i.v. inoculation with 106 CFU of the same strains (data from Table 1 and Fig. 1 (Fig. 2) . The four discordant strains included a capsular type 1 isolate and a type 6B isolate that killed mice when injected i.p. but not when injected i.v., a type 3 isolate that caused much more rapid death by i.p. injection than by i.v. injection, and a type 6B isolate that killed mice more rapidly when injected i.v. than when injected i.p. (Fig. 2) . The differences in time to death between the i.p. and i.v. routes were significant (P < 0.05) for three of these four strains.
The i.p. inoculation of BALB/cJ mice with 106 pneumococci revealed the same trend in time to death that we observed with CBAIN mice infected i.v. After i.p. infection, the median times of death of mice who died of capsular type 3, type 4, or group 6 infections were 2, 2, and 9 days, respectively. The median times of death with group 6 pneumococci were significantly different from those with type 3 or type 4 pneumococci (P < 0.001).
DISCUSSION
We observed that about 30% of fresh human isolates were virulent when injected i.v. into CBA/N and/or BALB/cJ mice. The data also demonstrated a very strong association of both virulence for mice and days to death with the capsular type of the infecting pneumococci. It is possible that the associations of virulence and days to death with capsular type occurred because the different capsular polysaccharides endowed pneumococci with substantially different virulence properties. An alternative explanation was that there were chance associations between different capsular types and genes responsible for different virulence phenotypes.
The latter possibility seemed unlikely for two reasons. (i) The PspA typing and PspA molecular weight data indicated that each of the isolates was probably clonally distinct. Thus, for example, the observations that all type 4 isolates were virulent whereas all type 14 isolates were avirulent were not the results of examining multiple examples of the same type 4 and type 14 clones. (ii) Data showing relatively random assortments of PspA and capsular types have indicated that there is frequent genetic exchange among wild pneumococci (10, 28) . If this is the case, it is unlikely, for example, that all type 14 pneumococci would lack virulence genes present in all type 4 pneumococci. Because of these considerations, we favor the hypothesis that the relative virulence of pneumococci of different capsular types for mice is dependent on the specific capsular types of the pneumococci.
It seems unlikely that the failure to detect mouse-virulent isolates of capsular types 14, 19, and 23 was due to high titers of naturally occurring antibody to the type polysaccharides of these isolates. If the presence of preexisting or induced antibody had prevented virulence of these strains, then CBA/N mice which lack the ability to make normal antibody responses to polysaccharides (6, 8, 22, 31, 33) should have been susceptible to infection with those types.
There is a clear relationship between capsular type and pneumococcal disease in humans (12, 14) . Types or groups 1, 3, 4, and 19 are all commonly seen in adult infections. Types or groups 6, 14, 19, and 23 are especially common in children and are less frequently seen in adult disease (14) . Although the strains used in this study were all of capsular types commonly found in human infections, we still observed a marked association between capsular type and mouse virulence. We also failed to observe any association between either the patients' disease diagnoses or the tissue sites of isolation and the virulence of the isolates in mice. These observations indicate that there are differences in some of the properties that make pneumococci virulent in humans and mice.
The longer time to death caused by most capsular 6A and 6B strains versus type 3 and 4 strains reflected more a difference in the nature of the disease than in the ability of the strains to kill. Strains giving very different times to death showed a similarly low percentage of survivors (and, where tested, LD50s). It seemed likely that the later times to death associated with type 6A and type 6B infections were an indication that these strains, while not able to cause rapid septic death, could manage significant growth in protected sites (24) .
Although previous studies with individual pneumococcal strains have indicated that pneumococci can be more virulent by the i.p. than the i.v. route (8, 24) , the conditions used in the present studies revealed similar virulence by i.v. and i.p. routes of infection for most of the strains tested. The capsular type 14, 19, and 23 strains were avirulent in BALB/cJ mice by either route, whereas most type 3, 4, 6A, and 6B strains showed similar virulence by both routes. There were only four exceptions. Of 15 strains not virulent i.v., only three were virulent when given i.p. Of 13 strains known to be virulent i.v., one was avirulent when given i.p. One explanation for the similar virulences we observed with i.v. and i.p. inoculations may be that suspending the bacteria in saline rather than sputum or culture medium (2, 13, 30) eliminated factors that might compromise the host defenses.
It is known that the capsule is necessary for virulence of pneumococci and that the amount of capsule can have an effect on virulence (19, 25, 29, 32) . Our failure to observe an association between degree of encapsulation and virulence does not argue against these earlier findings but merely indicates that all of these strains had adequate amounts of capsule. Our observation that strains of the same capsular type vary in virulence is probably an indication that these strains differed in other virulence properties. Several studies have demonstrated the existence of noncapsular virulence factors in pneumococci (3, 17, 20, 21, 23) . Future studies of the mechanisms responsible for the association of capsular type with virulence and time of death may provide insights into pneumococcal pathogenesis in humans.
